Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Type 2 Diabetes: full-pipeline trial registry
103 of 289 indexed Type 2 Diabetes trials are currently recruiting.
Corpus placement: #30 of 28,963 conditions by registered trial count.
289 US clinical trials · 103 currently recruiting · #30 of 28,963 conditions by registered trial count
Type 2 Diabetes: 289 US clinical trials tracked, 103 recruiting.
Type 2 Diabetes is the subject of 289 registered US clinical trials on ClinicalTrials.gov, 103 of them currently open to new participants. 56 are in Phase 3-4 (later-stage) and 42 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 20 of these trials.
Open enrollment snapshot
Type 2 Diabetes has 289 registered US clinical trials, 103 of them open to new participants right now, about 36% of the total.
- 103
- recruiting participants now
- 36%
- of trials open to enrollment
- 56
- in Phase 3-4 (later-stage)
- 20
- top sponsor: Eli Lilly and Company
Corpus placement: #30 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Type 2 Diabetes on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Type 2 Diabetes recruits in line with its size-band peers.
103 of 289 indexed trials (35.6%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Type 2 Diabetes trials is spread across many organizations.
Eli Lilly and Company accounts for 20 of 289 trials (6.9%). 140 distinct sponsors appear on at least one study for this condition label.
-
Typical Type 2 Diabetes enrolment sits around 96 participants.
Median target enrolment is 96 among the 289 trials that report a genuine target (sentinel values excluded). 145 of those (50.2%) plan for fewer than 100 participants.
-
Type 2 Diabetes research is mostly interventional.
257 interventional and 32 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
289 total, page 2 of 6
Designing Team Clinic for Youth With Type 2 Diabetes
Children's Hospital Los Angeles
NCT06658743
Personalized Nutrition for Type 2 Diabetes
University of Minnesota
NCT06784375
Families Implementing Good Health Traditions for Life
Morehouse School of Medicine
NCT07441655
Effect of Sleep Extension on Ceramides in People with Overweight and Obesity
University of Utah
NCT06180837
SGLT2i, Pioglitazone, and Ketone Production in T2D
The University of Texas Health Science Center at San Antonio
NCT07053319
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
Joslin Diabetes Center
NCT07271043
Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine
University of North Carolina, Chapel Hill
NCT07148713
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Mayo Clinic
NCT06976619
Extracellular Vesicles, Insulin Action, and Exercise
Rutgers, The State University of New Jersey
NCT06546085
Improving Appetite Self-Regulation in African American Adults With Type 2 Diabetes
University of North Carolina, Chapel Hill
NCT05741125
ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community
Sam Houston State University
NCT06028503
Type 2 Continuous Glucose Monitoring Academy
Children's Hospital Los Angeles
NCT06516640
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Medical College of Wisconsin
NCT05593549
Quantifying Hepatic Mitochondrial Fluxes in Humans
The University of Texas Health Science Center at San Antonio
NCT05305287
A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers
AdipoPharma
NCT07223333
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
NCT06739122
Enhancing Telemedicine for T2D
University of Pittsburgh
NCT06740435
The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults
AdventHealth Translational Research Institute
NCT03761446
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
Marzieh Salehi
NCT06706284
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
First Institute of All Medicines
NCT07124208
The Food for Health Study
University of Montana
NCT07254689
Diabetes Body Project 2
Joslin Diabetes Center
NCT07468188
Renal Mechanism of SGLT2 Inhibition
University of Colorado, Denver
NCT05507892
Liver Transplant CGM
Icahn School of Medicine at Mount Sinai
NCT07216508
Mobile App Logging for Diabetes in Pregnancy
Carolyn Zahler-Miller
NCT06005987
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
University of Alabama at Birmingham
NCT06902077
Mobile Health Dietary Intervention for Stroke Survivors With Prediabetes or Type 2 Diabetes
University of Hawaii
NCT07120334
Ketogenic Diet and Diabetes Demonstration Project
University of New Mexi
NCT06115265
Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D
University of Colorado, Denver
NCT07005362
DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes
Amsterdam UMC, location VUmc
NCT06983054
Ultrasound Effects on Glycemic Control in T2DM
Yale University
NCT05354947
High Fructose Diet, the Gut Microbiome, and Metabolic Health
Icahn School of Medicine at Mount Sinai
NCT06329544
Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes
University of California, San Diego
NCT06398093
Exercise and Protein Efficiency in T2D
University of Illinois at Urbana-Champaign
NCT07477067
Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function
Ohio State University
NCT06078683
THC Effects on Glucose in Type 2 Diabetes
University of California, San Diego
NCT05322213
Arginine Metabolism in Youth With Type 2 Diabetes
Baylor College of Medicine
NCT05477134
Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
Stanford University
NCT06836479
SGLTi, Hepatic Glucose Production and Ketogenesis
The University of Texas Health Science Center at San Antonio
NCT05960656
SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
The University of Texas Health Science Center at San Antonio
NCT07053306
Glycemic Excursion Minimization (GEM) to Outshine Health Disparities
Catherine Davis
NCT06236581
Heat Therapy in Type 2 Diabetes
Purdue University
NCT06596967
SGLT2i, Hepatic Glucose Production, and SNS
The University of Texas Health Science Center at San Antonio
NCT07053293
Mechanism of SGLT2 Inhibition in the Kidney
University of Michigan
NCT06291155
Enhancing Diabetes Care: Exposome &Amp; Sensors
University of Illinois at Chicago
NCT06989008
Precision Dosing of Metformin in Youth With T2D
University of California, San Francisco
NCT06120881
Circadian Intervention to Improve Cardiometabolic Health
University of Utah
NCT05943626
Pharmacist-led Continuous Glucose Monitoring
University of South Florida
NCT06572306
Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
Yale University
NCT06658067
Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes
AdventHealth Translational Research Institute
NCT04754581
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 21 |
| Phase 3 | 34 |
| Phase 4 | 22 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Type 2 Diabetes right now
103 recruiting of 289 indexed (36% open).
Phase mix: 56 late (III/IV) vs 42 early (I/II) (balanced across stages).
Top sponsor: Eli Lilly and Company (20 trials), 9 others listed. 50 shown below, recruiting first. #30 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Type 2 Diabetes?
PlainTrial tracks 289 US clinical trials for Type 2 Diabetes, of which 103 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Type 2 Diabetes?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.